New Insights into Gene Delivery to Human Neuronal Precursor NT2 Cells: A Comparative Study between Lipoplexes, Nioplexes, and Polyplexes

Molecular Pharmaceutics

Volumn 12, Issue 11, 2015, Pages 4056-4066

  Agirre, Mireia ^a,b   Ojeda, Edilberto ^a,b   Zarate, Jon ^a,b   Puras, Gustavo ^a,b   Grijalvo, Santiago ^b,c   Eritja, Ramón ^b,c   García Del Caño, Gontzal ^a   Barrondo, Sergio ^a,d   González Burguera, Imanol ^a   López De Jesús, Maider ^a,d   Sallés, Joan ^a,d   Pedraz, José Luis ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

endocytosis; nonviral vectors; NTera2 D1 cells; pCMS EGFP; transfection

Indexed keywords

DRUG CARRIER; LIPOPLEX; NIOPLEX; NIOSOME; POLYPLEX; UNCLASSIFIED DRUG; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; LIPID; LIPOSOME; POLYMER;

ARTICLE; CAVEOLA; CELL CULTURE; CELL VIABILITY; COMPARATIVE STUDY; CYTOMETRY; DRUG SYNTHESIS; ENDOCYTOSIS; ENDOSOME; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; ZETA POTENTIAL; ADMINISTRATION AND DOSAGE; CELL SURVIVAL; CHEMISTRY; EMBRYONAL CARCINOMA STEM CELL; GENE THERAPY; GENE TRANSFER; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; PLASMID; PROCEDURES;

CELL SURVIVAL; EMBRYONAL CARCINOMA STEM CELLS; ENDOCYTOSIS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GREEN FLUORESCENT PROTEINS; HUMANS; LIPIDS; LIPOSOMES; NEURONS; PLASMIDS; POLYMERS; TRANSFECTION;

EID: 84946429690     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.5b00496     Document Type: Article

References (56)

1. Andrews, P. W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro Dev. Biol. 1984, 103, 285-293 10.1016/0012-1606(84)90316-6
2. Trojanowski, J. Q.; Mantione, J. R.; Lee, J. H.; Seid, D. P.; You, T.; Inge, L. J.; Lee, V. M. Neurons derived from a human teratocarcinoma cell line establish molecular and structural polarity following transplantation into the rodent brain Exp. Neurol. 1993, 122, 283-294 10.1006/exnr.1993.1128
3. Trojanowski, J. Q.; Kleppner, S. R.; Hartley, R. S.; Miyazono, M.; Fraser, N. W.; Kesari, S.; Lee, V. M. Transfectable and transplantable postmitotic human neurons: a potential "platforma" for gene therapy of nervous system diseases Exp. Neurol. 1997, 144, 92-97 10.1006/exnr.1996.6393
4. Borlongan, C. V.; Tajima, Y.; Trojanowski, J. Q.; Lee, V. M.; Sanberg, P. R. Cerebral ischemia and CNS transplantation: differential effects of grafted fetal rat striatal cells and human neurons derived from a clonal cell line NeuroReport 1998, 9, 3703-3709 10.1097/00001756-199811160-00025
5. Andrews, P. W. From teratocarcinomas to embryonic stem cells Philos. Trans. R. Soc., B 2002, 357, 405-417 10.1098/rstb.2002.1058
6. Nelson, P. T.; Kondziolka, D.; Wechsler, L.; Goldstein, S.; Gebel, J.; DeCesare, S.; Elder, E. M.; Zhang, P. J.; Jacobs, A.; McGrogan, M.; Lee, V. M.; Trojanowski, J. Q. Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation Am. J. Pathol. 2002, 160, 1201-1206 10.1016/S0002-9440(10)62546-1
7. Hara, K.; Matsukawa, N.; Yasuhara, T.; Xu, L.; Yu, G.; Maki, M.; Kawase, T.; Hess, D. C.; Kim, S. U.; Borlongan, C. V. Transplantation of post-mitotic human neuroteratocarcinoma-overexpressing Nurr1 cells provides therapeutic benefits in experimental stroke: in vitro evidence of expedited neuronal differentiation and GDNF secretion J. Neurosci. Res. 2007, 85, 1240-1251 10.1002/jnr.21234
8. Newman, M. B.; Misiuta, I.; Willing, A. E.; Zigova, T.; Karl, R. C.; Borlongan, C. V.; Sanberg, P. R. Tumorigenicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells Stem Cells Dev. 2005, 14, 29-43 10.1089/scd.2005.14.29
9. Zhao, Y.; Wang, S. Human NT2 neural precursor-derived tumor-infiltrating cells as delivery vehicles for treatment of glioblastoma Hum. Gene Ther. 2010, 21, 683-694 10.1089/hum.2009.196
10. Aboody, K. S.; Brown, A.; Rainov, N. G.; Bower, K. A.; Liu, S.; Yang, W.; Small, J. E.; Herrlinger, U.; Ourednik, V.; Black, P. M.; Breakefield, X. O.; Snyder, E. Y. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas Proc. Natl. Acad. Sci. U. S. A. 2000, 97, 12846-12851 10.1073/pnas.97.23.12846
11. Benedetti, S.; Pirola, B.; Pollo, B.; Magrassi, L.; Bruzzone, M. G.; Rigamonti, D.; Galli, R.; Selleri, S.; Di Meco, F.; De Fraja, C.; Vescovi, A.; Cattaneo, E.; Finocchiaro, G. Gene therapy of experimental brain tumors using neural progenitor cells Nat. Med. 2000, 6, 447-450 10.1038/74710
12. Pleasure, S. J.; Page, C.; Lee, V. M. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons J. Neurosci. 1992, 12) 1802-1815
13. Watson, D. J.; Longhi, L.; Lee, E. B.; Fulp, C. T.; Fujimoto, S.; Royo, N. C.; Passini, M. A.; Trojanowski, J. Q.; Lee, V. M.; McIntosh, T. K.; Wolfe, J. H. Genetically modified NT2N human neuronal cells mediate long-term gene expression as CNS grafts in vivo and improve functional cognitive outcome following experimental traumatic brain injury J. Neuropathol. Exp. Neurol. 2003, 62, 368-380
14. Kofler, P.; Wiesenhofer, B.; Rehrl, C.; Baier, G.; Stockhammer, G.; Humpel, C. Liposome-mediated gene transfer into established CNS cell lines, primary glial cells, and in vivo Cell Transplant. 1998, 7, 175-185 10.1016/S0963-6897(97)00162-0
15. Nikcevic, G.; Kovacevic-Grujicic, N.; Stevanovic, M. Improved transfection efficiency of cultured human cells Cell Biol. Int. 2003, 27, 735-737 10.1016/S1065-6995(03)00143-4
16. Wang, Y.; Miao, L.; Satterlee, A.; Huang, L. Delivery of oligonucleotides with lipid nanoparticles Adv. Drug Delivery Rev. 2015, 87, 68 10.1016/j.addr.2015.02.007
17. Namvar, A.; Bolhassani, A.; Khairkhah, N.; Motevalli, F. Physicochemical properties of polymers: An important system to overcome the cell barriers in gene transfection Biopolymers 2015, 103, 363-375 10.1002/bip.22638
18. Dewey, R. A.; Morrissey, G.; Cowsill, C. M.; Stone, D.; Bolognani, F.; Dodd, N. J.; Southgate, T. D.; Klatzmann, D.; Lassmann, H.; Castro, M. G.; Lowenstein, P. R. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials Nat. Med. 1999, 5, 1256-1263 10.1038/15207
19. Fox, J. L. Gene-therapy death prompts broad civil lawsuit Nat. Biotechnol. 2000, 18, 1136 10.1038/81104
20. Rothe, M.; Modlich, U.; Schambach, A. Biosafety challenges for use of lentiviral vectors in gene therapy Curr. Gene Ther. 2014, 13, 453-468 10.2174/15665232113136660006
21. Li, S. D.; Huang, L. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery Gene Ther. 2006, 13, 1313-1319 10.1038/sj.gt.3302838
22. Pezzoli, D.; Chiesa, R.; De Nardo, L.; Candiani, G. We still have a long way to go to effectively deliver genes! J. Appl. Biomater. Funct. Mater. 2012, 10, 82-91 10.5301/JABFM.2012.9707
23. Sen, K.; Mandal, M. Second generation liposomal cancer therapeutics: transition from laboratory to clinic Int. J. Pharm. 2013, 448, 28-43 10.1016/j.ijpharm.2013.03.006
24. Dalby, B.; Cates, S.; Harris, A.; Ohki, E. C.; Tilkins, M. L.; Price, P. J.; Ciccarone, V. C. Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications Methods 2004, 33, 95-103 10.1016/j.ymeth.2003.11.023
25. Puras, G.; Mashal, M.; Zarate, J.; Agirre, M.; Ojeda, E.; Grijalvo, S.; Eritja, R.; Diaz-Tahoces, A.; Martinez Navarrete, G.; Aviles-Trigueros, M.; Fernandez, E.; Pedraz, J. L. A novel cationic niosome formulation for gene delivery to the retina J. Controlled Release 2014, 174, 27-36 10.1016/j.jconrel.2013.11.004
26. Ojeda, E.; Puras, G.; Agirre, M.; Zarate, J.; Grijalvo, S.; Pons, R.; Eritja, R.; Martinez-Navarrete, G.; Soto-Sanchez, C.; Fernandez, E.; Pedraz, J. L. Niosomes based on synthetic cationic lipids for gene delivery: the influence of polar head-groups on the transfection efficiency in HEK-293, ARPE-19 and MSC-D1 cells Org. Biomol. Chem. 2015, 13, 1068-1081 10.1039/C4OB02087A
27. Buschmann, M. D.; Merzouki, A.; Lavertu, M.; Thibault, M.; Jean, M.; Darras, V. Chitosans for delivery of nucleic acids Adv. Drug Delivery Rev. 2013, 65, 1234-1270 10.1016/j.addr.2013.07.005
28. Puras, G.; Zarate, J.; Aceves, M.; Murua, A.; Díaz, A. R.; Avilés-Triguero, M.; Fernández, E.; Pedraz, J. L. Low molecular weight oligochitosans for non-viral retinal gene therapy Eur. J. Pharm. Biopharm. 2013, 83, 131 10.1016/j.ejpb.2012.09.010
29. Agirre, M.; Zarate, J.; Ojeda, E.; Puras, G.; Rojas, L. A.; Alemany, R.; Pedraz, J. L. Delivery of an adenovirus vector plasmid by ultrapure oligochitosan based polyplexes Int. J. Pharm. 2015, 479, 312-319 10.1016/j.ijpharm.2014.12.062
30. Wang, T.; Upponi, J. R.; Torchilin, V. P. Design of multifunctional non-viral gene vectors to overcome physiological barriers: Dilemmas and strategies Int. J. Pharm. 2012, 427, 3-20 10.1016/j.ijpharm.2011.07.013
31. Hillaireau, H.; Couvreur, P. Nanocarriers' entry into the cell: relevance to drug delivery Cell. Mol. Life Sci. 2009, 66, 2873-2896 10.1007/s00018-009-0053-z
32. Grijalvo, S.; Ocampo, S. M.; Perales, J. C.; Eritja, R. Synthesis of lipid-oligonucleotide conjugates for RNA interference studies Chem. Biodiversity 2011, 8, 287-299 10.1002/cbdv.201000274
33. Zinchuk, V.; Zinchuk, O.; Okada, T. Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: pushing pixels to explore biological phenomena Acta Histochem. Cytochem. 2007, 40, 101-111 10.1267/ahc.07002
34. Mochizuki, S.; Kanegae, N.; Nishina, K.; Kamikawa, Y.; Koiwai, K.; Masunaga, H.; Sakurai, K. The role of the helper lipid dioleoylphosphatidylethanolamine (DOPE) for DNA transfection cooperating with a cationic lipid bearing ethylenediamine Biochim. Biophys. Acta, Biomembr. 2013, 1828, 412-418 10.1016/j.bbamem.2012.10.017
35. Pozzi, D.; Marchini, C.; Cardarelli, F.; Salomone, F.; Coppola, S.; Montani, M.; Zabaleta, M. E.; Digman, M. A.; Gratton, E.; Colapicchioni, V.; Caracciolo, G. Mechanistic evaluation of the transfection barriers involved in lipid-mediated gene delivery: interplay between nanostructure and composition Biochim. Biophys. Acta, Biomembr. 2014, 1838, 957-967 10.1016/j.bbamem.2013.11.014
36. Billiet, L.; Gomez, J. P.; Berchel, M.; Jaffres, P. A.; Le Gall, T.; Montier, T.; Bertrand, E.; Cheradame, H.; Guegan, P.; Mevel, M.; Pitard, B.; Benvegnu, T.; Lehn, P.; Pichon, C.; Midoux, P. Gene transfer by chemical vectors, and endocytosis routes of polyplexes, lipoplexes and lipopolyplexes in a myoblast cell line Biomaterials 2012, 33, 2980-2990 10.1016/j.biomaterials.2011.12.027
37. Sun, P.; Zhong, M.; Shi, X.; Li, Z. Anionic LPD complexes for gene delivery to macrophage: preparation, characterization and transfection in vitro J. Drug Target. 2008, 16, 668-678 10.1080/10611860802201381
38. Tagalakis, A. D.; Lee do, H. D.; Bienemann, A. S.; Zhou, H.; Munye, M. M.; Saraiva, L.; McCarthy, D.; Du, Z.; Vink, C. A.; Maeshima, R.; White, E. A.; Gustafsson, K.; Hart, S. L. Multifunctional, self-assembling anionic peptide-lipid nanocomplexes for targeted siRNA delivery Biomaterials 2014, 35, 8406-8415 10.1016/j.biomaterials.2014.06.003
39. Zhang, W.; Peng, F.; Zhou, T.; Huang, Y.; Zhang, L.; Ye, P.; Lu, M.; Yang, G.; Gai, Y.; Yang, T.; Ma, X.; Xiang, G. Targeted delivery of chemically modified anti-miR-221 to hepatocellular carcinoma with negatively charged liposomes Int. J. Nanomed. 2015, 10, 4825-4836 10.2147/IJN.S79598
40. Yang, Z.; Jiang, Z.; Cao, Z.; Zhang, C.; Gao, D.; Luo, X.; Zhang, X.; Luo, H.; Jiang, Q.; Liu, J. Multifunctional non-viral gene vectors with enhanced stability, improved cellular and nuclear uptake capability, and increased transfection efficiency Nanoscale 2014, 6, 10193-10206 10.1039/C4NR02395A
41. Douglas, K. L.; Piccirillo, C. A.; Tabrizian, M. Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors Eur. J. Pharm. Biopharm. 2008, 68, 676-687 10.1016/j.ejpb.2007.09.002
42. Klausner, E. A.; Zhang, Z.; Chapman, R. L.; Multack, R. F.; Volin, M. V. Ultrapure chitosan oligomers as carriers for corneal gene transfer Biomaterials 2010, 31, 1814-1820 10.1016/j.biomaterials.2009.10.031
43. Han, L.; Tang, C.; Yin, C. Enhanced antitumor efficacies of multifunctional nanocomplexes through knocking down the barriers for siRNA delivery Biomaterials 2015, 44, 111-121 10.1016/j.biomaterials.2014.12.020
44. Apaolaza, P. S.; Delgado, D.; del Pozo-Rodriguez, A.; Gascon, A. R.; Solinis, M. A. A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases Int. J. Pharm. 2014, 465, 413-426 10.1016/j.ijpharm.2014.02.038
45. Patil, S.; Sandberg, A.; Heckert, E.; Self, W.; Seal, S. Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential Biomaterials 2007, 28, 4600-4607 10.1016/j.biomaterials.2007.07.029
46. Gainza, G.; Pastor, M.; Aguirre, J. J.; Villullas, S.; Pedraz, J. L.; Hernandez, R. M.; Igartua, M. A novel strategy for the treatment of chronic wounds based on the topical administration of rhEGF-loaded lipid nanoparticles: In vitro bioactivity and in vivo effectiveness in healing-impaired db/db mice J. Controlled Release 2014, 185, 51-61 10.1016/j.jconrel.2014.04.032
47. Rejman, J.; Bragonzi, A.; Conese, M. Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes Mol. Ther. 2005, 12, 468-474 10.1016/j.ymthe.2005.03.038
48. Rejman, J.; Oberle, V.; Zuhorn, I. S.; Hoekstra, D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis Biochem. J. 2004, 377, 159-169 10.1042/bj20031253
49. Peng, S. F.; Tseng, M. T.; Ho, Y. C.; Wei, M. C.; Liao, Z. X.; Sung, H. W. Mechanisms of cellular uptake and intracellular trafficking with chitosan/DNA/poly(gamma-glutamic acid) complexes as a gene delivery vector Biomaterials 2011, 32, 239-248 10.1016/j.biomaterials.2010.08.081
50. Sahay, G.; Alakhova, D. Y.; Kabanov, A. V. Endocytosis of nanomedicines J. Controlled Release 2010, 145, 182-195 10.1016/j.jconrel.2010.01.036
51. Qaddoumi, M. G.; Ueda, H.; Yang, J.; Davda, J.; Labhasetwar, V.; Lee, V. H. The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers Pharm. Res. 2004, 21, 641-648 10.1023/B:PHAM.0000022411.47059.76
52. Ruiz de Garibay, A. P.; Solinis Aspiazu, M. A.; Rodriguez Gascon, A.; Ganjian, H.; Fuchs, R. Role of endocytic uptake in transfection efficiency of solid lipid nanoparticles-based nonviral vectors J. Gene Med. 2013, 15, 427-440 10.1002/jgm.2749
53. Iversen, T.; Skotland, T.; Sandvig, K. Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies Nano Today 2011, 6, 176-185 10.1016/j.nantod.2011.02.003
54. Pozzi, D.; Marchini, C.; Cardarelli, F.; Rossetta, A.; Colapicchioni, V.; Amici, A.; Montani, M.; Motta, S.; Brocca, P.; Cantu, L.; Caracciolo, G. Mechanistic understanding of gene delivery mediated by highly efficient multicomponent envelope-type nanoparticle systems Mol. Pharmaceutics 2013, 10, 4654-4665 10.1021/mp400470p
55. Varkouhi, A. K.; Scholte, M.; Storm, G.; Haisma, H. J. Endosomal escape pathways for delivery of biologicals J. Controlled Release 2011, 151, 220-228 10.1016/j.jconrel.2010.11.004
56. Agirre, M.; Zarate, J.; Puras, G.; Ojeda, E.; Pedraz, J. L. Improving transfection efficiency of ultrapure oligochitosan/DNA polyplexes by medium acidification Drug Delivery 2014, 22, 100 10.3109/10717544.2013.871373